glp 1 small molecule Synthetic GLP-1 secretagogues prepared by means of a three-component indole annulation strategy Potential oral small-molecule GLP-1R agonist.

When it was finally approved and I nervously took my script to the pharmacist, I learned it would be $500 a month

GLP-1 medications are meant to be long-term treatments for diabetes or obesity

Following the results of the SELECT trial, the FDA approved a new indication for Wegovy (semaglutide) in March 2024: to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight

References Ast J, Arvaniti A, Fine NHF, Nasteska D, Ashford FB, Stamataki Z, Koszegi Z, Bacon A, Jones BJ, Lucey MA, Sasaki S, Brierley DI, Hastoy B, Tomas A, DAgostino G, Reimann F, Lynn FC, Reissaus CA, Linnemann AK, DEste E, Calebiro D, Trapp S, Johnsson K, Podewin T, Broichhagen J, Hodson DJ

That may improve well in GLP ones, and that is because as you get these reactive oxygen species, they cause your mitochondria to misbehave

Patients considering GLP-1 therapy should always consult with their physician to discuss potential risks and benefits